24th July 2026, Friday

TechPharus

Latest Posts

HealthTech News

  • Large-scale brain analysis reveals multiple pathways to placebo effects on pain
    on July 24, 2026 at 7:20 pm

    Scientists have long known that expectations can reduce pain. What remained unclear was whether different ways of generating placebo effects rely on the same biological mechanisms. A new study published in Nature Communications now provides compelling evidence that they do not.

  • Your gut can get jet lag too: How not to waste the first days of your vacation
    on July 24, 2026 at 7:00 pm

    A dream vacation, an exotic destination, a long-haul flight and finally some well-deserved rest. The problem is that many travelers arrive at their destination only to spend the first days of their vacation struggling with fatigue, sleep disturbances, low energy levels and digestive issues. Researchers from Wroclaw Medical University point out that these symptoms may be caused by more than classic jet lag. A growing body of evidence suggests that time zone changes also affect the trillions of bacteria living in our intestines.

  • Redesigned lung cancer drug matches tumor control with fewer off-target interactions
    on July 24, 2026 at 6:40 pm

    Researchers at Moffitt Cancer Center have developed a new chemical approach that could help make targeted cancer medicines safer and more precise. The discovery gives scientists a new way to design drugs that bind more selectively to cancer-driving proteins while reducing unwanted interactions that can lead to side effects.

  • Spontaneous changes in brain state influence the readiness to form memories, neuroscientists find
    on July 24, 2026 at 6:20 pm

    Most everyday moments are quickly forgotten, while others stay with us for a lifetime. How the brain determines which memories are retained and which are lost remains an open question.

  • Potential new therapeutic targets for preeclampsia discovered
    on July 24, 2026 at 6:00 pm

    Unusual behavior in the cells of mothers and babies with preeclampsia may provide new therapeutic targets for the condition, a new UCL-led study finds.